get a key
steadybase-$ company GRCE
account_id none on file
legal_name Grace Therapeutics, Inc.
ticker GRCE
cik 1444192
domain gracetx.com
linkedin_company_url none on file
entry_point_account_id none on file
name Grace Therapeutics Inc.
exchange Nasdaq
sector Health Care
hq Princeton, NJ, United States
calls 0 filings 19 executives 4 family 0
why_nownone on file
callsnone on file
filings
DelAversano joined the Company in November 2023 as Vice President, Finance and serves as the principal financial officer and principal accounting officer.

filing / Jul 28, 2026 / receipt

By hosting the Annual Meeting online, we can communicate more effectively with our stockholders, enable increased attendance and participation from locations around the world, reduce costs, and increase overall efficiency and safety for us and our stockholders.

filing / Jul 28, 2026 / receipt

~15 rep sales force to reach ~50% of aSAH patients, concentrated in 242 centers

ir_statement / Sep 17, 2026 / receipt

~15 rep sales force to reach ~50% of aSAH patients, concentrated in 242 centers

ir_statement / Sep 15, 2026 / receipt

~15 rep sales force to reach ~50% of aSAH patients, concentrated in 242 centers

ir_statement / Sep 15, 2026 / receipt

~15 rep sales force to reach ~50% of aSAH patients, concentrated in 242 centers

ir_statement / Sep 15, 2026 / receipt

~15 rep sales force to reach ~50% of aSAH patients, concentrated in 242 centers

ir_statement / Sep 15, 2026 / receipt

~15 rep sales force to reach ~50% of aSAH patients, concentrated in 242 centers

ir_statement / Sep 15, 2026 / receipt

A reduction in ventilator days is great for the patient in reducing their risk of infections and benefitting their financial bottom line. It’s also good for hospital costs

ir_statement / Aug 8, 2026 / receipt

From an economic standpoint, fewer days in the ICU or on a ventilator certainly could justify the cost of the drug. Even a reduction of a single day is relevant. When it gets to be 2 or 3 days, then i

ir_statement / Aug 8, 2026 / receipt

GTx-104 target product profile is seen as valuable for its improved tolerability, cost savings, and easy IV use - with broad formulary inclusion by P&T committee

ir_statement / Aug 8, 2026 / receipt

HCPs highlighted that even modest reductions in ICU or ventilator time can have a significant impact on hospital costs, suggesting potential to deliver value beyond drug price-particularly given the h

ir_statement / Aug 8, 2026 / receipt

executives
Brian D. Ford Chief Financial Officer - receipt
Michael L. Derby director - receipt
Prashant Kohli Chief Executive Officer - receipt
R. Loch Macdonald Chief Medical Officer - receipt
familynone on file
upcoming
2026-11-12 earnings call scheduled ir
changes
2023-05-11 Chief Medical Officer, appointed sec_8k
2023-04-05 Chief Executive Officer, appointed sec_8k
2022-03-25 director, appointed sec_8k
2020-09-18 Chief Financial Officer, appointed sec_8k
mcp_package_hint
steadybase-$